Duodenal alpha-Synuclein Pathology and Enteric Gliosis in Advanced Parkinson's Disease
© 2023 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society..
BACKGROUND: The role of the gut-brain axis has been recently highlighted as a major contributor to Parkinson's disease (PD) physiopathology, with numerous studies investigating bidirectional transmission of pathological protein aggregates, such as α-synuclein (αSyn). However, the extent and the characteristics of pathology in the enteric nervous system have not been fully investigated.
OBJECTIVE: We characterized αSyn alterations and glial responses in duodenum biopsies of patients with PD by employing topography-specific sampling and conformation-specific αSyn antibodies.
METHODS: We examined 18 patients with advanced PD who underwent Duodopa percutaneous endoscopic gastrostomy and jejunal tube procedure, 4 untreated patients with early PD (disease duration <5 years), and 18 age- and -sex-matched healthy control subjects undergoing routine diagnostic endoscopy. A mean of four duodenal wall biopsies were sampled from each patient. Immunohistochemistry was performed for anti-aggregated αSyn (5G4) and glial fibrillary acidic protein antibodies. Morphometrical semiquantitative analysis was performed to characterize αSyn-5G4+ and glial fibrillary acidic protein-positive density and size.
RESULTS: Immunoreactivity for aggregated α-Syn was identified in all patients with PD (early and advanced) compared with controls. αSyn-5G4+ colocalized with neuronal marker β-III-tubulin. Evaluation of enteric glial cells demonstrated an increased size and density when compared with controls, suggesting reactive gliosis.
CONCLUSIONS: We found evidence of synuclein pathology and gliosis in the duodenum of patients with PD, including early de novo cases. Future studies are required to evaluate how early in the disease process duodenal pathology occurs and its possible contribution to levodopa effect in chronic patients. © 2023 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:38 |
|---|---|
| Enthalten in: |
Movement disorders : official journal of the Movement Disorder Society - 38(2023), 5 vom: 13. Mai, Seite 885-894 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Emmi, Aron [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Alpha-Synuclein |
|---|
| Anmerkungen: |
Date Completed 13.06.2023 Date Revised 16.06.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1002/mds.29358 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM353534250 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM353534250 | ||
| 003 | DE-627 | ||
| 005 | 20231226060225.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/mds.29358 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1178.xml |
| 035 | |a (DE-627)NLM353534250 | ||
| 035 | |a (NLM)36847308 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Emmi, Aron |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Duodenal alpha-Synuclein Pathology and Enteric Gliosis in Advanced Parkinson's Disease |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 13.06.2023 | ||
| 500 | |a Date Revised 16.06.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2023 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society. | ||
| 520 | |a BACKGROUND: The role of the gut-brain axis has been recently highlighted as a major contributor to Parkinson's disease (PD) physiopathology, with numerous studies investigating bidirectional transmission of pathological protein aggregates, such as α-synuclein (αSyn). However, the extent and the characteristics of pathology in the enteric nervous system have not been fully investigated | ||
| 520 | |a OBJECTIVE: We characterized αSyn alterations and glial responses in duodenum biopsies of patients with PD by employing topography-specific sampling and conformation-specific αSyn antibodies | ||
| 520 | |a METHODS: We examined 18 patients with advanced PD who underwent Duodopa percutaneous endoscopic gastrostomy and jejunal tube procedure, 4 untreated patients with early PD (disease duration <5 years), and 18 age- and -sex-matched healthy control subjects undergoing routine diagnostic endoscopy. A mean of four duodenal wall biopsies were sampled from each patient. Immunohistochemistry was performed for anti-aggregated αSyn (5G4) and glial fibrillary acidic protein antibodies. Morphometrical semiquantitative analysis was performed to characterize αSyn-5G4+ and glial fibrillary acidic protein-positive density and size | ||
| 520 | |a RESULTS: Immunoreactivity for aggregated α-Syn was identified in all patients with PD (early and advanced) compared with controls. αSyn-5G4+ colocalized with neuronal marker β-III-tubulin. Evaluation of enteric glial cells demonstrated an increased size and density when compared with controls, suggesting reactive gliosis | ||
| 520 | |a CONCLUSIONS: We found evidence of synuclein pathology and gliosis in the duodenum of patients with PD, including early de novo cases. Future studies are required to evaluate how early in the disease process duodenal pathology occurs and its possible contribution to levodopa effect in chronic patients. © 2023 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Parkinson's disease | |
| 650 | 4 | |a alpha-synuclein | |
| 650 | 4 | |a enteric nervous system | |
| 650 | 4 | |a gastrointestinal biopsies | |
| 650 | 4 | |a neuropathology | |
| 650 | 7 | |a alpha-Synuclein |2 NLM | |
| 650 | 7 | |a Glial Fibrillary Acidic Protein |2 NLM | |
| 700 | 1 | |a Sandre, Michele |e verfasserin |4 aut | |
| 700 | 1 | |a Russo, Francesco Paolo |e verfasserin |4 aut | |
| 700 | 1 | |a Tombesi, Giulia |e verfasserin |4 aut | |
| 700 | 1 | |a Garrì, Federica |e verfasserin |4 aut | |
| 700 | 1 | |a Campagnolo, Marta |e verfasserin |4 aut | |
| 700 | 1 | |a Carecchio, Miryam |e verfasserin |4 aut | |
| 700 | 1 | |a Biundo, Roberta |e verfasserin |4 aut | |
| 700 | 1 | |a Spolverato, Gaya |e verfasserin |4 aut | |
| 700 | 1 | |a Macchi, Veronica |e verfasserin |4 aut | |
| 700 | 1 | |a Savarino, Edoardo |e verfasserin |4 aut | |
| 700 | 1 | |a Farinati, Fabio |e verfasserin |4 aut | |
| 700 | 1 | |a Parchi, Piero |e verfasserin |4 aut | |
| 700 | 1 | |a Porzionato, Andrea |e verfasserin |4 aut | |
| 700 | 1 | |a Bubacco, Luigi |e verfasserin |4 aut | |
| 700 | 1 | |a De Caro, Raffaele |e verfasserin |4 aut | |
| 700 | 1 | |a Kovacs, Gabor G |e verfasserin |4 aut | |
| 700 | 1 | |a Antonini, Angelo |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Movement disorders : official journal of the Movement Disorder Society |d 1995 |g 38(2023), 5 vom: 13. Mai, Seite 885-894 |w (DE-627)NLM012945846 |x 1531-8257 |7 nnns |
| 773 | 1 | 8 | |g volume:38 |g year:2023 |g number:5 |g day:13 |g month:05 |g pages:885-894 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1002/mds.29358 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 38 |j 2023 |e 5 |b 13 |c 05 |h 885-894 | ||